APA (7th ed.) Citation

M, M., M, T., AW, T., MK, P., LR, I., X, H., . . . C, B. (2025). Inhibition of MCL-1 and MEK Overcomes MEK Inhibitor Resistance in Triple-Negative and Inflammatory Breast Cancers. Molecular cancer therapeutics, 24(9), 1453. https://doi.org/10.1158/1535-7163.MCT-24-0593

Chicago Style (17th ed.) Citation

M, Mughees, et al. "Inhibition of MCL-1 and MEK Overcomes MEK Inhibitor Resistance in Triple-Negative and Inflammatory Breast Cancers." Molecular Cancer Therapeutics 24, no. 9 (2025): 1453. https://doi.org/10.1158/1535-7163.MCT-24-0593.

MLA (9th ed.) Citation

M, Mughees, et al. "Inhibition of MCL-1 and MEK Overcomes MEK Inhibitor Resistance in Triple-Negative and Inflammatory Breast Cancers." Molecular Cancer Therapeutics, vol. 24, no. 9, 2025, p. 1453, https://doi.org/10.1158/1535-7163.MCT-24-0593.